Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and nay be a novel therapeutic approach.
Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and nay be a novel therapeutic approach.
复制标题
成纤维细胞生长因子受体 2 与卵巢透明细胞癌的总体生存率较差有关，可能是一种新的治疗方法。
DOI：
10.1097/igc.0000000000000414
复制
发表时间：
2015
影响因子：
4.8
通讯作者：
Harada T.
中科院分区：
文献类型：
--
作者：
Itamochi H;Oumi N;Oishi T;Taniguchi F;Shoji T;Fujiwara H;Sugiyama T;Suzuki M;Kigawa J;Harada T.
